- Home
- TSVT vs OPRX Comparison
TSVT vs OPRX Comparison
Compare TSVT & OPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSVT
- OPRX
- Stock Information
- Founded
- TSVT 2021
- OPRX 2006
- Country
- TSVT United States
- OPRX United States
- Employees
- TSVT N/A
- OPRX N/A
- Industry
- TSVT Biotechnology: Pharmaceutical Preparations
- OPRX Business Services
- Sector
- TSVT Health Care
- OPRX Consumer Discretionary
- Exchange
- TSVT Nasdaq
- OPRX Nasdaq
- Market Cap
- TSVT 128.5M
- OPRX 111.2M
- IPO Year
- TSVT N/A
- OPRX N/A
- Fundamental
- Price
- TSVT $2.45
- OPRX $5.41
- Analyst Decision
- TSVT Buy
- OPRX Buy
- Analyst Count
- TSVT 6
- OPRX 8
- Target Price
- TSVT $10.40
- OPRX $9.06
- AVG Volume (30 Days)
- TSVT 449.7K
- OPRX 255.6K
- Earning Date
- TSVT 03-04-2025
- OPRX 11-13-2024
- Dividend Yield
- TSVT N/A
- OPRX N/A
- EPS Growth
- TSVT N/A
- OPRX N/A
- EPS
- TSVT N/A
- OPRX N/A
- Revenue
- TSVT $45,620,000.00
- OPRX $88,179,506.00
- Revenue This Year
- TSVT N/A
- OPRX $28.59
- Revenue Next Year
- TSVT $36.09
- OPRX $10.52
- P/E Ratio
- TSVT N/A
- OPRX N/A
- Revenue Growth
- TSVT N/A
- OPRX 40.40
- 52 Week Low
- TSVT $2.35
- OPRX $3.78
- 52 Week High
- TSVT $6.40
- OPRX $16.65
- Technical
- Relative Strength Index (RSI)
- TSVT 35.00
- OPRX 54.39
- Support Level
- TSVT $2.36
- OPRX $4.72
- Resistance Level
- TSVT $2.53
- OPRX $5.14
- Average True Range (ATR)
- TSVT 0.18
- OPRX 0.45
- MACD
- TSVT 0.01
- OPRX -0.01
- Stochastic Oscillator
- TSVT 13.82
- OPRX 54.35
About TSVT 2seventy bio Inc.
2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment, focusing on researching, developing and commercializing potentially transformative treatments for cancer.
About OPRX OptimizeRx Corporation
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its products offering are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.